Mark I. Greene,Ramachandran Murali,Xin Cheng,Raphael Ottenbrite,Yingxin Xiao
申请号：
US14279506
公开号：
US09096607B2
申请日:
2014.05.16
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions.
